Official: Uthever® NMN Secures FDA NDI Clearance

Overview


Effepharm

Why choose Uthever®?

Stronger compliance: Uthever® has secured an FDA NDI notification (NDI 1267), confirming the compliance of its NMN ingredient.

Greater market recognition: Uthever® is widely trusted by brands and has been recognized as the *No.1 trademarked NMN ingredient brand in the U.S.

Clinically validated efficacy: Uthever® NMN completed the first large-scale human clinical study, providing scientific evidence for safety and efficacy.

What is the FDA-recognized recommended NMN dosage? What do our human clinical trial data reveal?

Download our latest NMN whitepaper to find out more.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.